Charles Nock
Hematology & Oncology · Cleveland, OHNPI 1235341538
Payments from drug & device makers
Across 38 payments — averaging $15,066 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$318K
- Novartis$237K
- Janssen Research & Development, LLC$18K
- Eisai Inc.$122
- Sanofi-aventis U.S. LLC$100
- Pinnacle Biologics, Inc$19
What the payments were for
- Travel & lodging$36847%
- Food & beverage$23230%
- Education$18423%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 14 | $317,541 |
| Novartis | 14 | $236,557 |
| Janssen Research & Development, LLC | 5 | $18,165 |
| Eisai Inc. | 3 | $122 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pinnacle Biologics, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILARIS$322
How this compares
$572,504 in reported general payments places this provider in the 85th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Afshin DowlatiCleveland$25.1M
- Brian HillCleveland$11.6M
- Christopher HoimesCleveland$7.5M
- Balazs HalmosCleveland$7M
- Dale ShepardCleveland$5.1M
- Paolo CaimiCleveland$4.2M
- Allison WinterCleveland$4.2M
- Nathan PennellCleveland$3.8M
- Ankit ManglaCleveland$3.3M
- David BajorCleveland$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.